Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yu-dong Cui

Showing results (11-20 of 26) with videos related to

Pageof 3
Sort By:
Molecular Medicine Reports|April 16, 2016
16α, 17α-epoxypregnenolone-20-oxime inhibits NO and IL-6 production in LPS-treated RAW264.7 cellsHu-Nan Sun, Ying-Hao Han, Li Feng, et al.
Journal of Cancer|September 19, 2022
Peroxiredoxin 5 protects HepG2 cells from ethyl β-carboline-3-carboxylate-induced cell death via ROS-dependent MAPK signalling pathwaysDan-Ping Xie, Yi-Xi Gong, Jaihyung Lee, et al.
Molecular Medicine Reports|April 6, 2018
Knockdown of peroxiredoxin V increases glutamate‑induced apoptosis in HT22 hippocampal neuron cellsGui-Nan Shen, Lei Liu, Li Feng, et al.
Heliyon|August 12, 2016
2-cyclohexylamino-5,8-dimethoxy-1,4-naphthoquinone inhibits LPS-induced BV2 microglial activation through MAPK/NF-kB signaling pathwaysHu-Nan Sun, Gui-Nan Shen, Yong-Zhe Jin, et al.
Molecular Medicine Reports|July 25, 2020
Peroxiredoxin I deficiency increases pancreatic β‑cell apoptosis after streptozotocin stimulation via the AKT/GSK3β signaling pathwayMei-Hua Jin, Gui-Nan Shen, Ying-Hua Jin, et al.
Antioxidants (Basel, Switzerland)|December 22, 2019
Peroxiredoxin II Maintains the Mitochondrial Membrane Potential against Alcohol-Induced Apoptosis in HT22 CellsMei-Hua Jin, Jia-Bin Yu, Hu-Nan Sun, et al.
Molecular Medicine Reports|June 15, 2018
Peroxiredoxin I deficiency increases LPS‑induced lethal shock in miceHu-Nan Sun, Li Feng, Ai-Guo Wang, et al.
In Vivo (Athens, Greece)|December 29, 2019
Deletion of Peroxiredoxin II Inhibits the Growth of Mouse Primary Mesenchymal Stem Cells Through Induction of the G<sub>0</sub>/G<sub>1</sub> Cell-cycle Arrest and Activation of AKT/GSK3β/β-Catenin SignalingYing-Hao Han, Mei-Hua Jin, Ying-Hua Jin, et al.
Biological & Pharmaceutical Bulletin|July 4, 2014
16α,17α-Epoxypregnenolone-20-oxime prevent LPS-induced NO production and iNOS expression in BV-2 microglial cells by inhibiting JNK phosphorylationHu-Nan Sun, Mei-Hua Jin, Bing Han, et al.
Anticancer Research|July 3, 2019
Peroxiredoxin V Reduces β-Lapachone-induced Apoptosis of Colon Cancer CellsYue Liu, Taeho Kwon, Ji-Su Kim, et al.
Pageof 3

Showing results (11-20 of 26) with videos related to

Sort By:
Pageof 3
Molecular Medicine Reports|April 16, 2016
16α, 17α-epoxypregnenolone-20-oxime inhibits NO and IL-6 production in LPS-treated RAW264.7 cellsHu-Nan Sun, Ying-Hao Han, Li Feng, et al.
Journal of Cancer|September 19, 2022
Peroxiredoxin 5 protects HepG2 cells from ethyl β-carboline-3-carboxylate-induced cell death via ROS-dependent MAPK signalling pathwaysDan-Ping Xie, Yi-Xi Gong, Jaihyung Lee, et al.
Molecular Medicine Reports|April 6, 2018
Knockdown of peroxiredoxin V increases glutamate‑induced apoptosis in HT22 hippocampal neuron cellsGui-Nan Shen, Lei Liu, Li Feng, et al.
Heliyon|August 12, 2016
2-cyclohexylamino-5,8-dimethoxy-1,4-naphthoquinone inhibits LPS-induced BV2 microglial activation through MAPK/NF-kB signaling pathwaysHu-Nan Sun, Gui-Nan Shen, Yong-Zhe Jin, et al.
Molecular Medicine Reports|July 25, 2020
Peroxiredoxin I deficiency increases pancreatic β‑cell apoptosis after streptozotocin stimulation via the AKT/GSK3β signaling pathwayMei-Hua Jin, Gui-Nan Shen, Ying-Hua Jin, et al.
Antioxidants (Basel, Switzerland)|December 22, 2019
Peroxiredoxin II Maintains the Mitochondrial Membrane Potential against Alcohol-Induced Apoptosis in HT22 CellsMei-Hua Jin, Jia-Bin Yu, Hu-Nan Sun, et al.
Molecular Medicine Reports|June 15, 2018
Peroxiredoxin I deficiency increases LPS‑induced lethal shock in miceHu-Nan Sun, Li Feng, Ai-Guo Wang, et al.
In Vivo (Athens, Greece)|December 29, 2019
Deletion of Peroxiredoxin II Inhibits the Growth of Mouse Primary Mesenchymal Stem Cells Through Induction of the G<sub>0</sub>/G<sub>1</sub> Cell-cycle Arrest and Activation of AKT/GSK3β/β-Catenin SignalingYing-Hao Han, Mei-Hua Jin, Ying-Hua Jin, et al.
Biological & Pharmaceutical Bulletin|July 4, 2014
16α,17α-Epoxypregnenolone-20-oxime prevent LPS-induced NO production and iNOS expression in BV-2 microglial cells by inhibiting JNK phosphorylationHu-Nan Sun, Mei-Hua Jin, Bing Han, et al.
Anticancer Research|July 3, 2019
Peroxiredoxin V Reduces β-Lapachone-induced Apoptosis of Colon Cancer CellsYue Liu, Taeho Kwon, Ji-Su Kim, et al.
Pageof 3